Audit 303626

FY End
2023-06-30
Total Expended
$6.64M
Findings
0
Programs
3
Year: 2023 Accepted: 2024-04-16
Auditor: Leaf & Cole LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.394 Cancer Detection and Diagnosis Research $3.22M Yes 0
93.395 Cancer Treatment Research $498,873 Yes 0
12.420 Military Medical Research and Development $74,112 Yes 0

Contacts

Name Title Type
EAZXZLPJYJZ2 Amie Fennelly Auditee
8584509999 Jill Branch Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: Proteogenomics Research Institute for Systems Medicine has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance.